Figure 3 — Investigating the mechanisms of Modified Xiaoyaosan (tiaogan-liqi prescription) in suppressing the progression of atherosclerosis, by means of integrative pharmacology and experimental validation

Research Paper|Volume 13, Issue 8|pp. 11411–11432

Investigating the mechanisms of Modified Xiaoyaosan (tiaogan-liqi prescription) in suppressing the progression of atherosclerosis, by means of integrative pharmacology and experimental validation

Back to articleFigure 3(3 of 11)

100%

Figure 3.GO and KEGG enrichment analysis of the key targets. (A) The top 20 significantly enriched terms in the GO biological processes; (B) The top 25 significantly enriched terms in KEGG pathways.